Northwestern University Feinberg School of Medicine
Skip to main content

Lurie Cancer Center Members Elected to Leadership of the American Society of Hematology (ASH)

The American Society of Hematology (ASH), the world’s largest professional society concerned with the causes and treatment of blood disorders, announced the election of Alexis Thompson, MD, MPH and Jane Winter, MD, from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University to its Executive Committee, the governing body of the organization, for terms beginning in December, following the 2015 ASH Annual Meeting.

Alexis A. Thompson, MD, MPH, will serve a one-year term as vice president, followed by successive terms as president-elect and president. She is head of the hematology section of the Division of Hematology Oncology Transplantation and Director of the Comprehensive Thalassemia Program at Ann and Robert H. Lurie Children’s Hospital of Chicago, where she also serves as the A. Watson and Sarah Armour Endowed Chair for Childhood Cancer and Blood Disorders. Dr. Thompson is also Associate Director of Equity and Minority Health at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Dr. Thompson’s major fields of interest include sickle cell disease, thalassemia, transfusional iron overload, and stem cell transplantation for pediatric patients. In her position as vice president, Dr. Thompson aims to enhance training programs to attract the next generation of scientists to hematology as well as increase collaboration between ASH and global partners to improve hematology care and capacity around the world. Dr. Thompson served as an ASH councilor from 2010 – 2013 and is a member of the ASH Sickle Cell Task Force. She has served as a mentor for the Minority Medical Student Award Program for more than 10 years and is currently a reviewer for ASH’s journal, Blood.

Jane N. Winter, MD, will serve a four-year term as councilor. She is Professor of Medicine in the Division of Hematology/Oncology at Northwestern University Feinberg School of Medicine and a member of the Lurie Cancer Center. Dr. Winter’s research interests include the clinical and biologic markers of prognosis in diffuse large B-cell lymphoma and clinical trials with novel agents in lymphoma. An ASH member for more than 30 years, Dr. Winter has recently served as chair of the Committee on Educational Affairs as well as faculty for the ASH Clinical Research Training Institute and the ASH/European Hematology Association Translational Research Training in Hematology.

Back to top